Yahoo Suche Web Suche

  1. siemens.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht

    Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. Life Science Solutions from Siemens: Leading the Way in Science. Learn More Today!

Suchergebnisse

  1. Suchergebnisse:
  1. Spark’s Gene Therapy Innovation Center. Located in West Philadelphia in the heart of University City, our 500,000-square-foot, multi-story Gene Therapy Innovation Center will serve as a Roche center of excellence for gene therapy manufacturing globally. The new space will allow cross-functional teams to come together and work side by side to ...

  2. The company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2019, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8]

    • 2013; 10 years ago
    • 368 (2019)
  3. www.roche.com › innovation › structureRoche | Spark

    Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.

  4. Philadelphia, PA 87,040 followers. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. View all 1,036 employees. About us. At Spark® Therapeutics, we...

  5. 23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.

  6. 17. Dez. 2019 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. The company challenges the inevitability of genetic diseases,...